Principal Investigator
Macarena De La Fuente
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20210950
Clinical Trial Summary
Olutasidenib (FT-2102) Treatment Plan for a Patient with an Advanced Solid Tumor or Glioma with an IDH1 Mutation
Phase
N/A
Funding Agency/Sponsor
Institutional
Disease
Neurological Cancer
Contact Information
Phone Number
+1 (305) 2431194